Goodkin, D E <br/><br/>
Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.  [electronic resource] 

 -  Annals of neurology  Jan 1995 
 - 30-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Standard No.: </label>10.1002/ana.410370108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Chronic Disease<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunosuppression Therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>Treatment Failure<br/>Treatment Outcome